9. Nurse education prior to intravesical instillation
To ensure patient and nurse safety, it is essential that all nurses administering the treatment meet specific prerequisites, maintaining a universal standard of education, understanding and competence. The nurse specialist administering intravesical treatment must be trained and assessed by a competent practitioner in accordance with local guidelines. It is also important that the nurse specialist keep their intravesical-treatment skills up to date to ensure continued competence, with a prerequisite that they be deemed competent in urethral catheterisation (Table 5) [50].
To ensure compliance with current safety regulations, all staff involved in handling MMC or BCG (including physicians, nurses and employees involved in receiving, transporting or storing these agents) must receive comprehensive information and training regarding the associated hazards. This training should be provided at the start of their assignment to areas in which the drugs are present. The employer should provide annual refresher information and training, which is essential to maintain awareness and adherence to safe handling practices [25, 26].
The initiation of intravesical treatment should be determined by the urological surgeon or through the multidisciplinary team meeting. In countries in which specialist nurses are licensed to prescribe medication, it continues to be good practice to make this decision in consultation with the urologist and multidisciplinary team.
Table 5. Nurse education for bladder instillation
| Maintain knowledge/skill in: | Rationale |
|---|---|
| Bladder cancer pathway | To ensure treatment plans and further investigations take place as required |
| Indication for treatment |
|
| Data supporting use of treatment | To help patients understand the benefits of treatment where necessary, as some patients may not want this information |
| Importance of counselling the patient regarding the treatment | To help ensure patient preference, promote compliance and build trust and confidence, enabling the patient to take an active role in their care |
| Pharmacokinetics and pharmacodynamics of the agent being used | All nurses have a responsibility to understand medication they administer to patients to help the patient understand how the treatment works and how it affects their disease. |
| Contraindications of treatments | To ensure patient safety by avoiding treatments that could cause harm or adverse reactions |
The physical and health hazards of MMC and BCG in the work area and the measures employees can take to protect themselves from these hazards. |
|
| Management of spillages and waste disposal |
|
| Anatomy and physiology of the urinary tract | An understanding of the urinary tract anatomy and physiology ensures safe, effective care and management of urinary conditions and treatment |
| Competent in urethral catheterisation | To ensure patient-centred care while maintaining safe and effective administration of the treatment and reducing risk of side effects. |
| Side effects of the agent being used |
|
| Dose/schedule | To ensure the treatment is administered according to the summary of product characteristics (SmPC). |
| Personal protective equipment to be used when performing intravesical instillation |
|
| The carcinogenic potential and reproductive hazards of these drugs | To understand the importance of avoiding drug exposure, especially early in pregnancy, ensures informed decision making about the hazards involved |
9.1 Recordkeeping
The competent practitioner who educates the nurse should prepare training records, including the following information:
- Dates of the training sessions
- Contents or a summary of the training sessions
- Names and qualifications of the persons conducting the training
- Names and job titles of all persons attending the training sessions
Training records should be maintained for three years from the date on which the training was held [26].
| Recommendations | LE | GR |
|---|---|---|
| All staff involved must receive training on handling hazardous drugs. | 4 | C |
| Intravesical therapies must be administered by a trained nurse and assessed by a competent practitioner. | 4 | C |
| The decision to initiate intravesical therapies must be made by a multidisciplinary team. | 4 | C |
| Training records must be maintained. | 4 | C |
